Skip to main content
BioAdvance NewsPortfolio NewsRelmada Therapeutics

Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million in Connection with Going Public Transaction

By June 16, 2014November 1st, 2024No Comments

Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million in Connection with Going Public Transaction
Read more here